Preparation method of brucella capsid vaccine strain
A technology for Brucella and vaccine strains, applied in the fields of molecular biology and microbiology, can solve the problems of high cost and unsuitability for large-scale production, achieve good genetic stability, good safety and immunogenicity, avoid Biosecurity Risk Effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0043] Such as figure 1 Shown, the method for the preparation Brucella shell vaccine strain of taking Brucella canis RM6 / 66 bacterial strain as example comprises three steps altogether:
[0044] 1. Construction of temperature-controlled cleavage suicide plasmid pBK-CMV-SacB-ΔB0419-TLC
[0045] (1) PCR amplification of upper and lower homology arm sequences of specific genes in the genome of Brucella canis RM6 / 66 strain
[0046] 1) Primer design
[0047] Upstream homology arm primer B0419 upstream primer:
[0048] 5′- GGATCC GTGATTATCTCCGACGTTTCATC-3′ (with BamHI site),
[0049] Upstream homology arm primer B0419 downstream primer:
[0050] 5′- CTCGAG GGTTTGCAGCCTTGCCTGCGCGGT-3′ (with XhoI site);
[0051] Downstream homology arm primer B0419 upstream primer:
[0052] 5′- CTCGAG AGGCCAGCCCAGACGACCGCGCT-3′ (with XhoI site),
[0053] Downstream homology arm primer B0419 downstream primer:
[0054] 5′- TCTAGA CTATGCCTGTTCTTCCATCGG-3' (with XbaI site).
[0055] 2) G...
Embodiment 2
[0087] The resistance detection of embodiment 2 canine brucella capsid vaccine strains
[0088] The brucella shell vaccine strain that the present invention constructs is inoculated in containing kanamycin resistance Kan R (100μg / mL) TSB liquid medium, cultured at 28°C for 3 days, or coated with kanamycin-resistant Kan R (100μg / mL) TSA plate, cultured at 28°C for 7 days; observe whether the liquid is turbid or a single colony grows on the plate.
[0089] The result shows: the TSB liquid culture medium is clear and there is no single bacterium colony growth on the TSA flat plate, illustrates that the Brucella bacterial shell vaccine strain that the present invention builds can't contain kanamycin resistance Kan R Growth in the culture medium further indicates that the Brucella capsid vaccine strain is a non-resistance strain, which avoids the existence of resistance genes and the biosafety risk of horizontal transfer of resistance genes in the host.
Embodiment 3
[0091] Genetic Stability Detection of Capsid Vaccine Strains of Brucella canis
[0092] The brucella shell vaccine strain that the present invention constructs is inoculated on TSB liquid culture medium and is passed down continuously, records and saves each generation bacterium liquid, confirms the stability of its passage, with specific primer (upstream homologous arm primer B0419 upstream Primers and downstream homology arm primer B0419 downstream primer) for PCR verification.
[0093] The result is as Figure 9 As shown, the 1st to 30th generation BCG-ΔB0419 strains were amplified by B0419 gene primers to obtain a 3647bp band, while the genomic DNA of the control group Brucella canis only amplified a 2190bp band. It shows that after the temperature-controlled lysis component is inserted into the Brucella canis B0419 gene sequence, there is no loss of specific fragments or reverse mutation of the original B0419 gene, which further indicates that the Brucella capsid vaccine...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com